Page 315 - AIDSBK23C
P. 315

Page 315



               216     Galai N, Park LP, Wesch J, Visscher B, Riddler S, Margolick JB. Effect of smoking on
                       the clinical progression of HIV-1 infection. J Acquir Immune Defic Syndr. 1997;15:451-
                       458.

               217     Bessinger R, Clark R, Kissinger P, Rice J, Coughlin S. Pregnancy is not associated with
                       the progression of HIV disease in women attending an HIV outpatient program. Am J
                       Epidemiol. 1998;147:434-440.

               218     Pratt G, Gascoyne K, Cunningham K, Tunbridge A. Human immunodeficiency virus
                       (HIV) in older people. Age Ageing. 2010;39:289-294.

               219     Xiang J, Wunschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, Stapleton
                       JT. Effect ofcoinfection with GB virus C on survival among patients with HIV infection.
                       N Engl J Med. 2001;345:707-714.

               220     Stone CA, Kawai K, Kupka R, Fawzi WW. Role of selenium in HIV infection. Nutr Rev.
                       2010;68:671-681.

               221     Barker E, Mackewicz CE, Reyes-Teran G, et al. Virological and immunological features
                       of long-term human immunodeficiency virus-infected individuals who have remained
                       asymptomatic compared with those who have progressed to acquired immunodeficiency
                       syndrome. Blood. 1998;92:3105-3114.

               222     Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF, et al. Studies
                       in subjects with long-term nonprogressive human immunodeficiency virus infection. N
                       Engl J Med. 1995;332:209-216.

               223     O'Connell KA, Bailey JR, Blankson JN. Elucidating the elite: mechanisms of control in
                       HIV-1 infection. Trends Pharmacol Sci. 2009;30:631-637.

               224     Okulicz JF, Lambotte O. Epidemiology and clinical characteristics of elite controllers.
                       Curr Opin HIV AIDS. 2011;6(3):163-8.

               225     Ioannidis JPA, Rosenberg PS, Goedert JJ, et al. Effects of CCR5-delta32, CCR2-64I, and
                       SDF-1-3’A alleles on HIV-1 disease progression: an international meta-analysis of
                       individual patient data. Ann Intern Med. 2001;135:782-795.

               226     Reynes J, Portales P, Segondy M, et al. CD4 T cell surface CCR5 density as a host factor
                       in HIV-1 disease progression. AIDS. 2001;15:1627-1634.

               227     Faure S, Meyer L, Genin E, Pellet P, Debre P, Theodorou I, Combadiere C. Deleterious
                       genetic influence of CX3CR1 genotypes on HIV-1 disease progression. J Acquir Immune
                       Defic Syndr. 2003;32:335-337.

               228     Balog K, Minarovits J. Nef: a pleiotropic modulator of primate lentivirus infectivity and
   310   311   312   313   314   315   316   317   318   319   320